THERAPEUTIC OR PROPHYLACTIC AGENT FOR MULTIPLE SCLEROSIS

Disclosed is a therapeutic or prophylactic agent for multiple sclerosis. The therapeutic or prophylactic agent comprises a glycine derivative having a specific structure (e.g., a compound [(E)-2-(2,6-dichlorobenzamide)-5-[4-( isopropyl-pyrimidin-2-ylamino)phenyl]pent-4-enoic acid]) or a pharmacologi...

Full description

Saved in:
Bibliographic Details
Main Authors HAYASHI, KENICHI, MEGURO, HIROYUKI, KAINO, MIE
Format Patent
LanguageEnglish
French
Published 27.12.2007
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed is a therapeutic or prophylactic agent for multiple sclerosis. The therapeutic or prophylactic agent comprises a glycine derivative having a specific structure (e.g., a compound [(E)-2-(2,6-dichlorobenzamide)-5-[4-( isopropyl-pyrimidin-2-ylamino)phenyl]pent-4-enoic acid]) or a pharmacologica lly acceptable salt thereof as an active ingredient. The therapeutic or prop hylactic agent shows excellent absorption properties and in vivo stability u pon being orally administered and has a significant therapeutic or prophylac tic effect.
Bibliography:Application Number: CA20072655573